Chen Y - Search Results

1

Metalloprotease inhibitor TIMP proteins control FGF-2 bioavailability and regulate skeletal growth.

Saw S, Aiken A, Fang H, McKee TD, Bregant S, Sanchez O, Chen Y, Weiss A, Dickson BC, Czarny B, Sinha A, Fosang A, Dive V, Waterhouse PD, Kislinger T, Khokha R. Saw S, et al. Among authors: chen y. J Cell Biol. 2019 Sep 2;218(9):3134-3152. doi: 10.1083/jcb.201906059. Epub 2019 Aug 1. J Cell Biol. 2019. PMID: 31371388 Free PMC article.

2

TIMP Loss Activates Metalloproteinase-TNFα-DKK1 Axis To Compromise Wnt Signaling and Bone Mass.

Chen Y, Aiken A, Saw S, Weiss A, Fang H, Khokha R. Chen Y, et al. J Bone Miner Res. 2019 Jan;34(1):182-194. doi: 10.1002/jbmr.3585. Epub 2018 Oct 4. J Bone Miner Res. 2019. PMID: 30216540 Free article.

3

Cross-species genomics identifies DLG2 as a tumor suppressor in osteosarcoma.

Shao YW, Wood GA, Lu J, Tang QL, Liu J, Molyneux S, Chen Y, Fang H, Adissu H, McKee T, Waterhouse P, Khokha R. Shao YW, et al. Among authors: chen y. Oncogene. 2019 Jan;38(2):291-298. doi: 10.1038/s41388-018-0444-4. Epub 2018 Aug 9. Oncogene. 2019. PMID: 30093633 Free PMC article.

4

RANKL blockade prevents and treats aggressive osteosarcomas.

Chen Y, Di Grappa MA, Molyneux SD, McKee TD, Waterhouse P, Penninger JM, Khokha R. Chen Y, et al. Sci Transl Med. 2015 Dec 9;7(317):317ra197. doi: 10.1126/scitranslmed.aad0295. Sci Transl Med. 2015. PMID: 26659571

5

CDH4 is a novel determinant of osteosarcoma tumorigenesis and metastasis.

Tang Q, Lu J, Zou C, Shao Y, Chen Y, Narala S, Fang H, Xu H, Wang J, Shen J, Khokha R. Tang Q, et al. Among authors: chen y. Oncogene. 2018 Jul;37(27):3617-3630. doi: 10.1038/s41388-018-0231-2. Epub 2018 Apr 3. Oncogene. 2018. PMID: 29610525

6

Tissue inhibitor of metalloproteinase 1 suppresses growth and differentiation of osteoblasts and differentiation of osteoclasts by targeting the AKT pathway.

Xi Y, Huang H, Zhao Z, Ma J, Chen Y. Xi Y, et al. Among authors: chen y. Exp Cell Res. 2020 Apr 15;389(2):111930. doi: 10.1016/j.yexcr.2020.111930. Epub 2020 Feb 27. Exp Cell Res. 2020. PMID: 32113948

7

PTEN promotes intervertebral disc degeneration by regulating nucleus pulposus cell behaviors.

Xi Y, Ma J, Chen Y. Xi Y, et al. Among authors: chen y. Cell Biol Int. 2020 Feb;44(2):583-592. doi: 10.1002/cbin.11258. Epub 2019 Nov 12. Cell Biol Int. 2020. PMID: 31663655

8

Corrigendum to "Tissue inhibitor of metalloproteinase 1 suppresses growth and differentiation of osteoblasts and osteoclasts by targeting the AKT pathway" [Exp. Cell Res. 389 (2020) 111930-11940].

Xi Y, Huang H, Zhao Z, Ma J, Chen Y. Xi Y, et al. Among authors: chen y. Exp Cell Res. 2020 Sep 1;394(1):112189. doi: 10.1016/j.yexcr.2020.112189. Epub 2020 Jul 25. Exp Cell Res. 2020. PMID: 32800209 No abstract available.

9

Beta-catenin signaling pathway is crucial for bone morphogenetic protein 2 to induce new bone formation.

Chen Y, Whetstone HC, Youn A, Nadesan P, Chow EC, Lin AC, Alman BA. Chen Y, et al. J Biol Chem. 2007 Jan 5;282(1):526-33. doi: 10.1074/jbc.M602700200. Epub 2006 Nov 3. J Biol Chem. 2007. PMID: 17085452 Free article.

10

PTEN loss activates a functional AKT/CXCR4 signaling axis to potentiate tumor growth and lung metastasis in human osteosarcoma cells.

Xi Y, Qi Z, Ma J, Chen Y. Xi Y, et al. Among authors: chen y. Clin Exp Metastasis. 2020 Feb;37(1):173-185. doi: 10.1007/s10585-019-09998-7. Epub 2019 Sep 30. Clin Exp Metastasis. 2020. PMID: 31571016

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

178,686 results

Search Page

Filters